Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted

被引：3
|
作者：
Barraud, Damien [1 ]
Besancon, Lonni [2 ]
Bik, Elisabeth M. [3 ]
Billy, Eric
Clarot, Franck [4 ]
Frank, Fabrice
Guihur, Anthony [5 ]
Hajage, David [6 ]
Lacombe, Karine [7 ]
Maisonneuve, Herve [8 ]
Molimard, Mathieu [9 ,10 ]
Mulot, Matthieu [11 ]
Samuel, Alexander
机构：
[1] CHR Metz Thionville, Dept Intens Care Med, F-57530 Ars, France
[2] Linkoping Univ, Media & Informat Technol, S-58183 Norrkoping, Sweden
[3] Harbers Bik LLC, San Francisco, CA USA
[4] Univ Rouen, Dept Forens Med & Pathol, F-76031 Rouen, France
[5] Univ Lausanne UNIL, Fac Biol & Med, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland
[6] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Ctr pharmacoepidemiol,Inst Pierre Louis epidemiol, F-75231 Paris, France
[7] Sorbonne Univ, Hop St Antoine, AP HP, IPLESP, F-75231 Paris, France
[8] Univ Paris Cite, Sch Med, F-75106 Paris, France
[9] Univ Bordeaux, Serv pharmacol CHU Bordeaux, CHU Bordeaux, INSERM,U657, F-33600 Pessac, France
[10] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland
[11] Univ Neuchatel, Hosp Network Neuchatel, CH-2000 Neuchatel, Switzerland
来源：
THERAPIE | 2023年 / 78卷 / 04期
关键词：
COVID-19; Hydroxychloroquine; Retraction; Ethics; Clinical research;
D O I：
10.1016/j.therap.2023.06.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：437 / 440
页数：4
相关论文
共 50 条
  • [1] RETRACTED: Why are we vaccinating children against COVID-19? (Retracted Article)
    Kostoff, Ronald N.
    Calina, Daniela
    Kanduc, Darja
    Briggs, Michael B.
    Vlachoyiannopoulos, Panayiotis
    Svistunov, Andrey A.
    Tsatsakis, Aristidis
    TOXICOLOGY REPORTS, 2021, 8 : 1665 - 1684
  • [2] The use of Hydroxychloroquine in the Treatment of COVID-19
    Tecen-Yucel, Kamer
    Kara, Emre
    Demirkan, Kutay
    Unal, Serhat
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2020, 25 (03): : 283 - 291
  • [3] Hydroxychloroquine and COVID-19: The endgame!
    Deplanque, Dominique
    THERAPIE, 2023, 78 (04): : 343 - 344
  • [4] Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
    Kaur, Amritpal
    Chaudhary, Gaurav
    Singh, Pargat
    Arora, Sandeep
    Kaur, Rajwinder
    CURRENT DRUG TARGETS, 2021, 22 (13) : 1536 - 1547
  • [5] Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
    Sebastián Ibáñez
    Oriela Martínez
    Francisca Valenzuela
    Francisco Silva
    Omar Valenzuela
    Clinical Rheumatology, 2020, 39 : 2461 - 2465
  • [6] Hydroxychloroquine and chloroquine in COVID-19: should they be used as standard therapy?
    Ibanez, Sebastian
    Martinez, Oriela
    Valenzuela, Francisca
    Silva, Francisco
    Valenzuela, Omar
    CLINICAL RHEUMATOLOGY, 2020, 39 (08) : 2461 - 2465
  • [7] Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
    Celik, Hulya Gamze
    Keske, Siran
    Sener, Ulker
    Tekbas, Muge
    Kapmaz, Mahir
    Sahin, Sukru Taylan
    Ozyildirim, Asli
    Aytekin, Saide
    Aytekin, Vedat
    Ergonul, Onder
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 102 : 389 - 391
  • [8] Why we should not 'just use age' for COVID-19 vaccine prioritisation
    Smith, Maxwell J.
    JOURNAL OF MEDICAL ETHICS, 2022, 48 (08) : 538 - 541
  • [9] Why should we use convalescent plasma for COVID-19
    Franchini, Massimo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 77 : 150 - 151
  • [10] Hydroxychloroquine and Covid-19 saga
    Gocko, Xavier
    Tudrej, Benoit
    Fintz, Axel
    Plotton, Catherine
    Boussageon, Remy
    Pouchain, Denis
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2021, (173): : 224 - 229
12345